Impact of COVID-19 Vaccination on Balance Function Among Adolescents: A Long-Term Perspective
1 other identifier
observational
270
1 country
1
Brief Summary
Long term impact of COVID 19 vaccination on dizziness-related disability and balance in adolescence
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 11, 2023
CompletedStudy Start
First participant enrolled
December 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedFirst Posted
Study publicly available on registry
July 16, 2024
CompletedJuly 16, 2025
July 1, 2025
5 months
August 11, 2023
July 12, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Impact on Balance
The pediatric balance scale is used to assess balance (Lowest score =0 " worst"- Maximum score is 56 " Perfect Balance"
Through study completion, an average of 1 day - 1 year after taking the vaccine
Functional Disability
The Dizziness Handicap Inventory is used to assess functional disability related to dizziness
Through study completion, an average of 1 day - 1 year after taking the vaccine
Secondary Outcomes (2)
Emotional Disability
Through study completion, an average of 1 day - 1 year after taking the vaccine
Physical Disability
Through study completion, an average of 1 day - 1 year after taking the vaccine
Interventions
Vaccination
Eligibility Criteria
* Adolescence age range 10-17 * Vaccinated by any available SARS -COV-2 Vaccinations
You may qualify if:
- Adolescence age range 10-17
- received a dose or more of an approved COVID-19 vaccine at least one year before the study enrollment.
- the ability to complete all assessment measures independently.
You may not qualify if:
- vestibular or neurological disorders diagnosed before vaccination.
- mixed COVID-19 vaccine types.
- a history of traumatic brain injury.
- current use of medications that affect balance.
- documented COVID-19 infection within three months of assessment.
- physical limitations that prevented them from completing balance testing.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sinai Universitylead
Study Sites (1)
Sinai University
Ismailia, Ismailia Governorate, 11749, Egypt
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
August 11, 2023
First Posted
July 16, 2024
Study Start
December 6, 2023
Primary Completion
April 30, 2024
Study Completion
July 1, 2024
Last Updated
July 16, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share